Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy
Clinical trial NCT04266028 · COMPLETED
Trial details
- NCT number
- NCT04266028
- Sponsor
- Desentum Oy
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-11
- Primary completion
- 2021-05-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.